Amedeo Smart

Free Medical Literature Service

 

Amedeo

Pancreatitis
  Free Subscription

Articles published in
J Gastroenterol
    April 2024
  1. MATSUMOTO K, Fujimori N, Ichihara K, Takeno A, et al
    Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction.
    J Gastroenterol. 2024 Apr 29. doi: 10.1007/s00535-024-02103.
    >> Share

    February 2024
  2. NAGAO K, Sakai A, Tsumura H, Iemoto T, et al
    Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.
    J Gastroenterol. 2024 Feb 29. doi: 10.1007/s00535-024-02083.
    >> Share

    January 2024
  3. KASHIRO A, Kobayashi M, Oh T, Miyamoto M, et al
    Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
    J Gastroenterol. 2024 Jan 23. doi: 10.1007/s00535-023-02072.
    >> Share

  4. ABE S, Masuda A, Matsumoto T, Inoue J, et al
    Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2024 Jan 20. doi: 10.1007/s00535-023-02069.
    >> Share

    November 2023
  5. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
    J Gastroenterol. 2023 Nov 25. doi: 10.1007/s00535-023-02058.
    >> Share

  6. TAKEUCHI C, Sato J, Yamamichi N, Kageyama-Yahara N, et al
    Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation.
    J Gastroenterol. 2023 Nov 14. doi: 10.1007/s00535-023-02055.
    >> Share

    September 2023
  7. OZONO Y, Kawakami H, Uchiyama N, Hatada H, et al
    Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary-pancreatic cancers.
    J Gastroenterol. 2023 Sep 12. doi: 10.1007/s00535-023-02037.
    >> Share

  8. OKUSAKA T, Saiura A, Shimada K, Ikeda M, et al
    Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
    J Gastroenterol. 2023 Sep 7. doi: 10.1007/s00535-023-02033.
    >> Share

    August 2023
  9. FISCHMAN M, Elias A, Klein A, Cohen Y, et al
    The association between phosphate level at admission and early mortality in acute pancreatitis.
    J Gastroenterol. 2023 Aug 18. doi: 10.1007/s00535-023-02034.
    >> Share

    July 2023
  10. OYAMA H, Hamada T, Nakai Y, Tanaka M, et al
    Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases.
    J Gastroenterol. 2023 Jul 29. doi: 10.1007/s00535-023-02028.
    >> Share

  11. ASHINA S, Masuda A, Yamakawa K, Hamada T, et al
    A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2023 Jul 21. doi: 10.1007/s00535-023-02020.
    >> Share

    June 2023
  12. TOMIMARU Y, Eguchi H, Shimomura Y, Kitamura T, et al
    Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society.
    J Gastroenterol. 2023 Jun 17. doi: 10.1007/s00535-023-01988.
    >> Share

    May 2023
  13. KAWASAKI Y, Hijioka S, Nagashio Y, Maruki Y, et al
    Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    J Gastroenterol. 2023 May 8. doi: 10.1007/s00535-023-01995.
    >> Share

    April 2023
  14. SAKAI A, Masuda A, Kodama Y
    Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?
    J Gastroenterol. 2023 Apr 30. doi: 10.1007/s00535-023-01994.
    >> Share

  15. MURAKAMI M, Fujimori N, Nakata K, Nakamura M, et al
    Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    J Gastroenterol. 2023 Apr 26. doi: 10.1007/s00535-023-01987.
    >> Share

  16. SAKAKIDA T, Ishikawa T, Doi T, Morita R, et al
    Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan.
    J Gastroenterol. 2023 Apr 7. doi: 10.1007/s00535-023-01986.
    >> Share

    January 2023
  17. TANAKA T, Masuda A, Inoue J, Hamada T, et al
    Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2023 Jan 27. doi: 10.1007/s00535-022-01939.
    >> Share

    December 2022
  18. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    Correction: The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Dec 23. doi: 10.1007/s00535-022-01944.
    >> Share

    November 2022
  19. IWASHITA T, Iwata K, Hamada T, Saito T, et al
    Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives.
    J Gastroenterol. 2022 Nov 7. pii: 10.1007/s00535-022-01935.
    >> Share

    October 2022
  20. HISADA Y, Hijioka S, Ikeda G, Maehara K, et al
    Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01926.
    >> Share

    September 2022
  21. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    >> Share

  22. KAWAKUBO K, Fernandez-Del Castillo C, Liss AS
    Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 17. pii: 10.1007/s00535-022-01922.
    >> Share

  23. KAWAKUBO K, Castillo CF, Liss AS
    Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 1. pii: 10.1007/s00535-022-01915.
    >> Share

    August 2022
  24. SHIMIZU K, Ito T, Irisawa A, Ohtsuka T, et al
    Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
    J Gastroenterol. 2022 Aug 22. pii: 10.1007/s00535-022-01911.
    >> Share

  25. UCHIDA K, Okazaki K
    Current status of type 1 (IgG4-related) autoimmune pancreatitis.
    J Gastroenterol. 2022 Aug 2. pii: 10.1007/s00535-022-01891.
    >> Share

    July 2022
  26. KANDA T, Wakiya T, Ishido K, Kimura N, et al
    Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas.
    J Gastroenterol. 2022 Jul 3. pii: 10.1007/s00535-022-01898.
    >> Share

    June 2022
  27. YAMAMOTO K, Iwadate D, Kato H, Nakai Y, et al
    Targeting autophagy as a therapeutic strategy against pancreatic cancer.
    J Gastroenterol. 2022 Jun 21. pii: 10.1007/s00535-022-01889.
    >> Share

  28. OKADA Y, Nakasone H, Nakamura Y, Kawamura M, et al
    Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation.
    J Gastroenterol. 2022 Jun 3. pii: 10.1007/s00535-022-01881.
    >> Share

    April 2022
  29. GAO L, Zhang H, Li G, Ye B, et al
    The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis.
    J Gastroenterol. 2022 Apr 29. pii: 10.1007/s00535-022-01876.
    >> Share

    February 2022
  30. OKAZAKI K, Kawa S, Kamisawa T, Ikeura T, et al
    Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020.
    J Gastroenterol. 2022 Feb 22. pii: 10.1007/s00535-022-01857.
    >> Share

    January 2022
  31. KAWABATA H, Ono Y, Tamamura N, Oyama K, et al
    Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
    J Gastroenterol. 2022 Jan 11. pii: 10.1007/s00535-021-01846.
    >> Share

    August 2021
  32. CAO Z, Qiu J, Guo J, Xiong G, et al
    A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.
    J Gastroenterol. 2021 Aug 28. pii: 10.1007/s00535-021-01818.
    >> Share

  33. MASAKI Y, Nakase H, Tsuji Y, Nojima M, et al
    The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.
    J Gastroenterol. 2021 Aug 24. pii: 10.1007/s00535-021-01817.
    >> Share

    July 2021
  34. CANNON A, Thompson CM, Bhatia R, Armstrong KA, et al
    Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2021 Jul 19. pii: 10.1007/s00535-021-01800.
    >> Share

  35. ASTIAZARAN-SYMONDS E, Goldstein AM
    A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
    J Gastroenterol. 2021 Jul 13. pii: 10.1007/s00535-021-01806.
    >> Share

    June 2021
  36. KURIYAMA K, Kodama Y, Shiokawa M, Nishikawa Y, et al
    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.
    J Gastroenterol. 2021 Jun 14. pii: 10.1007/s00535-021-01779.
    >> Share

    March 2021
  37. WANG WQ, Zhang WH, Gao HL, Huang D, et al
    A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    J Gastroenterol. 2021 Mar 19. pii: 10.1007/s00535-021-01777.
    >> Share

    February 2021
  38. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.
    >> Share

  39. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.
    >> Share

    October 2020
  40. SAKAI A, Masuda A, Eguchi T, Anami T, et al
    Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation.
    J Gastroenterol. 2020 Oct 28. pii: 10.1007/s00535-020-01739.
    >> Share

  41. TEZUKA K, Okamura Y, Sugiura T, Ito T, et al
    The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    J Gastroenterol. 2020 Oct 22. pii: 10.1007/s00535-020-01730.
    >> Share

    August 2019
  42. HAKUTA R, Hamada T, Nakai Y, Oyama H, et al
    Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes.
    J Gastroenterol. 2019 Aug 31. pii: 10.1007/s00535-019-01612.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016